Physician profile
Evan D Goldstein
NPI 1467449033
$818.83
in general payments reported to CMS, 2019-2025
11 companies · $124 in 2025
The $124 reported for 2025 was more than what a typical Emergency Medical Services provider received nationally (typical 2025 total: $70.35).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31.94 · 2020: $40.99 · 2021: $107 · 2022: $148 · 2023: $245 · 2024: $123 · 2025: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $471 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $471.01 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $236.93 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $208.60 | 2020-2024 | Brilinta, Andexxa |
| Janssen Pharmaceuticals, INC | $83.01 | 2020-2023 | Xarelto |
| Alexion Pharmaceuticals, INC. | $78.03 | 2021-2022 | |
| Csl Behring | $58.69 | 2023-2024 | Kcentra |
| Ucb, INC. | $54.00 | 2023-2024 | Nayzilam, Briviact |
| Melinta Therapeutics, LLC | $38.13 | 2025 | Rezzayo, Kimyrsa, Orbactiv |
| Octapharma USA, INC. | $18.12 | 2025 | Balfaxar |
| E.R. Squibb & Sons, L.L.C. | $16.91 | 2021 | |
| Mylan Specialty L.P. | $14.80 | 2019 | |
| Ambu INC. | $11.61 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evan Goldstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.